Prostaglandin F2alpha (PGF2alpha) and prolactin secretion in rats.
Plasma prolactin and F-prostaglandins (PGF) were measured anesthetized male Sprague-Dawley rats before and at 15, 30, 45 and 60 minutes following i.v. injection of either PGF2alpha (4 mg/kg), chlorpromazine, 1 mg/kg or chlorpormazine (1 mg/kg) after pretreatment with i.p. indomethacin (2 mg/kg). Following PGF2alpha administration, plasma prolactin levels increased significantly only at 15 and 30 minutes in spite of extremely high PGF levels throughout 60 minutes. Besides the expected rise in plasma prolactin, chlorpromazine caused a transient but statistically significant increase in PGF. Indomethacin blocked the chlorpormazine-induced PGF rise but not prolactin increase. Animals stressed with ether anesthesia showed elevation of plasma prolactin, which was not blocked by indomethacin although PGF concentration fell. Theese results indicate that PGF2alpha can stimulate prolactin release. This effect does not appear to be physiologic since very high PGF levels are required. Furthermore, blockade of prostaglandin synthesis by indomethacin does not prevent the release of prolactin in response to chlorpormazine or stress. Our findings do not support a possible role of PGFs as intermediaries in prolactin release. However, it is possible that PGFs may work through other mechanisms not investigated in our study.
D000818:Animals; D002746:Chlorpromazine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D011388:Prolactin / Q000097:blood* / Q000378:metabolism; D011460:Prostaglandins F / Q000097:blood* / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D013312:Stress, Physiological / Q000503:physiopathology; D013997:Time Factors
D011460:Prostaglandins F; D011388:Prolactin; D002746:Chlorpromazine; D007213:Indomethacin